Neuropathix, Inc (NPTX)
Stock Price: $0.1900 USD
-0.0100 (-5.00%)
Updated Jan 20, 2021 3:59 PM EST - Market closed
| Market Cap | 13.55M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -3.71M |
| Shares Out | 74.26M |
| EPS (ttm) | -0.05 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 20 |
| Last Price | $0.1900 |
| Previous Close | $0.2000 |
| Change ($) | -0.0100 |
| Change (%) | -5.00% |
| Day's Open | 0.2100 |
| Day's Range | 0.1900 - 0.2275 |
| Day's Volume | 147,934 |
| 52-Week Range | 0.13 - 0.545 |
News
There are no news available yet.
About NPTX
Neuropathix, a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics from its proprietary cannabinoid product platform. It engages in the research and development of chemical entities, such as KLS-13019, as well as its related molecules; and synthetic cannabidiol therapeutics through pre-clinical drug discovery and development processes for use in the disease indications of overt hepatic encephalopathy, chronic traumatic encephalopathy, and chemotherapy induced peripheral neuropathy. The c... [Read more...]
| Industry Biotechnology | Founded 2010 |
| CEO Dean Petkanas | Employees 5 |
| Stock Exchange OTCMKTS | Ticker Symbol NPTX |